What's New
| Complex Cases in VTE: Applications to Clinical Practice Jori May, MD; Stephan Moll, MD; Paul Lewis, MD, FAAFP, ABPM-CI, CPE, CPHIMS In this accredited activity, a panel of experts in hematology/VTE and primary care explore various complex clinical cases with many nuances that require evaluation of the individual patient with a DVT or PE, and how those details may impact treatment. |
| VTE in the Real World: Questions, Myths, and Future Directions Jori May, MD; Stephan Moll, MD; and Paul Lewis, MD, FAAFP, ABPM-CI, CPE, CPHIMS In this accredited activity, a panel of experts in hematology/VTE and primary care address the most common questions, including questions concerning imaging studies, travel and movement, anticoagulation interruption, prevention of future VTEs and the use of estrogen-containing regimens in women following a VTE. The role of thrombophilia testing in the patient, and potentially in the patient’s family members, is discussed in detail, as is patient types and scenarios in which referral to a specialist is appropriate. |
| Practical Strategies for Long-Term VTE Management in Unique Patient Populations Jori May, MD; Stephan Moll, MD; and William Braun, PharmD This accredited activity will feature a panel of experts in hematology/VTE and pharmacy providing clear and specific recommendations for best practices in these challenging and unique patients – as well as guidance on clinical strategies that are less effective or should be avoided in elderly patients, patients with renal disease, obese patients, women, patients with COVID, and patients in whom anticoagulation therapy seems to have failed. |
| Chronic VTE: Practical Management Strategies and Long-term Complications Jori May, MD; Stephan Moll, MD; and William Braun, PharmD In this accredited activity, a panel of experts in hematology/VTE and pharmacy address practical considerations in the management of patients on long-term anticoagulation for chronic VTE. Faculty will discuss drug-drug interactions, over-the-counter medications and supplements, and safe use of pain medications in these patients, as well as strategies for effective perioperative interruption of anticoagulants. |
| Practical Strategies for Determining the Duration of Anticoagulation in Patients Diagnosed with VTE Jori May, MD; Stephan Moll, MD; and Paul Lewis, MD, FAAFP, ABPM-CI, CPE, CPHIMS In this accredited activity, a panel of experts in hematology/VTE and primary care address the critical question of the duration of anticoagulation in a patient who has experienced a DVT or PE. Faculty will outline the factors that will guide the nonspecialist in determining a patient’s risk of recurrence and identifying whether the patient should undergo anticoagulation of short- or long-term duration. |
| Modern Practices in Anticoagulation: Practical Strategies for Diagnosis and Management of Acute VTE Jori May, MD; Stephan Moll, MD; and Paul Lewis, MD, FAAFP, ABPM-CI, CPE, CPHIMS In this accredited activity, a panel of experts in hematology/VTE and primary care discuss the challenge of diagnosing and treating VTE in a busy non-specialist setting. Topics include risk stratification strategies, differential diagnosis tools, and effective clinical strategies for managing patients who present with symptoms of a DVT or PE. |
| The Challenges at the Intersection of VTE and Obesity: Defining the Issues Rachel P. Rosovsky, MD, MPH; Stephan Moll, MD; and Bishoy Ragheb, PharmD, BCACP, CDE, CACP, CTTS This activity, the first in a two-part series, focuses on the effects of obesity on VTE and anticoagulation therapy. Follow along with the faculty as they clarify the relationship between obesity and VTE and outline strategies for tailoring anticoagulation therapy based on body mass index (BMI) and other relevant factors. A case study is included to help demonstrate the challenges of – and solutions to – anticoagulation therapy in this patient population |
| Anticoagulation in Obese Patients: Applied Clinical Practices in the Non-specialist Setting Rachel P. Rosovsky, MD, MPH; Stephan Moll, MD; and Bishoy Ragheb, PharmD, BCACP, CDE, CACP, CTTS This activity, the second in a two-part series, explores anticoagulation treatment strategies in special patient groups, including patients with heavy menses, renal issues, or a history of bariatric surgery. This activity is designed to equip its participants with strategies for ensuring optimal anticoagulation in a variety of situations in patients both with and without obesity. |
| Monograph-The Role of Care Transitions in Critical Access Hospitals This monograph details the beneficial effects of a targeted Care Transition Intervention (CTI) on VTE outcomes in Black rural populations. This program, which was piloted in a Critical Access Hospital catchment region in Mississippi, demonstrates how CTIs might reduce VTE-associated hospital readmissions in underserved populations. Explore this important study and its implications for VTE care across the country. |
| VTE Risk Assessment Tool How do you estimate the pretest probability for acute DVT and PE? |